Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B D Walker

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Journal of Virology|February 7, 2001
Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infectionL Alexander, E Weiskopf, T C Greenough, et al.
Nature|October 12, 2000
Immune control of HIV-1 after early treatment of acute infectionE S Rosenberg, M Altfeld, S H Poon, et al.
The Journal of Infectious Diseases|June 26, 2001
Definition of an optimal cytotoxic T lymphocyte epitope in the latently expressed Kaposi's sarcoma-associated herpesvirus kaposin proteinC Brander, P O'Connor, T Suscovich, et al.
The Journal of Clinical Investigation|June 17, 1998
Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infectionC Brander, K E Hartman, A K Trocha, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2010
Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllersB Julg, F Pereyra, M J Buzón, et al.
Journal of Virology|December 25, 2003
Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infectionR Draenert, C L Verrill, Y Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2001
The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individualsM M Addo, M Altfeld, E S Rosenberg, et al.
Journal of Virology|June 11, 1999
Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infectionC M Hay, D J Ruhl, N O Basgoz, et al.
Journal of Virology|January 11, 2001
Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assaysP J Goulder, M M Addo, M A Altfeld, et al.
Journal of Virology|August 23, 2000
Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assayM A Altfeld, A Trocha, R L Eldridge, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Journal of Virology|February 7, 2001
Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infectionL Alexander, E Weiskopf, T C Greenough, et al.
Nature|October 12, 2000
Immune control of HIV-1 after early treatment of acute infectionE S Rosenberg, M Altfeld, S H Poon, et al.
The Journal of Infectious Diseases|June 26, 2001
Definition of an optimal cytotoxic T lymphocyte epitope in the latently expressed Kaposi's sarcoma-associated herpesvirus kaposin proteinC Brander, P O'Connor, T Suscovich, et al.
The Journal of Clinical Investigation|June 17, 1998
Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infectionC Brander, K E Hartman, A K Trocha, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2010
Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllersB Julg, F Pereyra, M J Buzón, et al.
Journal of Virology|December 25, 2003
Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infectionR Draenert, C L Verrill, Y Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2001
The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individualsM M Addo, M Altfeld, E S Rosenberg, et al.
Journal of Virology|June 11, 1999
Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infectionC M Hay, D J Ruhl, N O Basgoz, et al.
Journal of Virology|January 11, 2001
Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assaysP J Goulder, M M Addo, M A Altfeld, et al.
Journal of Virology|August 23, 2000
Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assayM A Altfeld, A Trocha, R L Eldridge, et al.
Pageof 17